4//SEC Filing
Riehle J Nick 4
Accession 0001181431-09-058119
CIK 0001333763other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 11:48 AM ET
Size
12.0 KB
Accession
0001181431-09-058119
Insider Transaction Report
Form 4
Riehle J Nick
Chief Financial Officer
Transactions
- Purchase
Common Stock
2009-12-21$2.20/sh+2,500$5,500→ 63,183 total
Holdings
- 50,000
Stock Option (Right to Buy)
Exercise: $1.78Exp: 2019-01-22→ Common Stock (50,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $6.50Exp: 2018-01-24→ Common Stock (50,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $5.68Exp: 2017-02-06→ Common Stock (50,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $3.26Exp: 2016-01-19→ Common Stock (50,000 underlying) - 68,923
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (68,923 underlying)
Footnotes (6)
- [F1]This transaction was executed in multiple trades at prices ranging from $2.199 to $2.20. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]Option vests in four equal annual installments beginning on January 22, 2010.
- [F3]Option vests in four equal annual installments beginning on January 24, 2009.
- [F4]Option vests in four equal annual installments beginning on February 6, 2008.
- [F5]Option vests in four equal annual installments beginning on January 19, 2007.
- [F6]Option vests in four equal annual installments beginning on January 10, 2006.
Documents
Issuer
Chelsea Therapeutics International, Ltd.
CIK 0001333763
Entity typeother
Related Parties
1- filerCIK 0001316746
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 11:48 AM ET
- Size
- 12.0 KB